Ubs Group Ag Surmodics Inc Transaction History

Ubs Group Ag

$555 Billion
Q2 2025

A detailed history of Ubs Group Ag transactions in Surmodics Inc stock. As of the latest transaction made, Ubs Group Ag holds 422,724 shares of SRDX stock, worth $13.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

422,724

Previous 65,742 543.0%

Holding current value

$13.7 Million

Previous $2.01 Million 525.76%

% of portfolio

0.0%

Previous 0.0%

34 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$26.76 - $31.1 $9.55 Million - $11.1 Million	356,982 Added 543.0%	422,724 $12.6 Million
Q1 2025 May 13, 2025	BUY	$26.71 - $39.71 $1.57 Million - $2.34 Million	58,835 Added 851.82%	65,742 $2.01 Million
Q4 2024 Feb 14, 2025	BUY	$37.5 - $40.13 $126,525 - $135,398	3,374 Added 95.5%	6,907 $273,000
Q3 2024 Nov 14, 2024	SELL	$38.47 - $42.24 $48,472 - $53,222	-1,260 Reduced 26.29%	3,533 $137,000
Q2 2024 Aug 13, 2024	SELL	$25.39 - $42.1 $250,903 - $416,032	-9,882 Reduced 67.34%	4,793 $201,000
Q1 2024 May 13, 2024	SELL	$27.44 - $35.56 $6,613 - $8,569	-241 Reduced 1.62%	14,675 $430,000
Q4 2023 Feb 09, 2024	BUY	$28.47 - $38.49 $135,004 - $182,519	4,742 Added 46.61%	14,916 $542,000
Q3 2023 Nov 09, 2023	SELL	$28.28 - $38.36 $121,943 - $165,408	-4,312 Reduced 29.77%	10,174 $326,000
Q2 2023 Aug 11, 2023	BUY	$17.67 - $31.31 $132,754 - $235,232	7,513 Added 107.74%	14,486 $453,000
Q1 2023 May 12, 2023	BUY	$17.13 - $38.52 $45,531 - $102,386	2,658 Added 61.6%	6,973 $158,000
Q4 2022 Feb 08, 2023	BUY	$29.44 - $37.31 $59,616 - $75,552	2,025 Added 88.43%	4,315 $147,000
Q3 2022 Nov 10, 2022	BUY	$28.84 - $38.92 $38,645 - $52,152	1,340 Added 141.05%	2,290 $70,000
Q2 2022 Aug 10, 2022	SELL	$33.25 - $45.11 $147,064 - $199,521	-4,423 Reduced 82.32%	950 $35,000
Q1 2022 May 16, 2022	SELL	$40.68 - $49.72 $212,430 - $259,637	-5,222 Reduced 49.29%	5,373 $243,000
Q4 2021 Feb 14, 2022	BUY	$43.21 - $57.6 $261,290 - $348,307	6,047 Added 132.96%	10,595 $510,000
Q3 2021 Nov 15, 2021	SELL	$52.8 - $60.32 $90,129 - $102,966	-1,707 Reduced 27.29%	4,548 $253,000
Q2 2021 Aug 13, 2021	SELL	$51.29 - $59.15 $104,836 - $120,902	-2,044 Reduced 24.63%	6,255 $340,000
Q1 2021 May 12, 2021	SELL	$42.18 - $56.07 $87,312 - $116,064	-2,070 Reduced 19.96%	8,299 $465,000
Q4 2020 Feb 11, 2021	BUY	$35.18 - $43.52 $143,252 - $177,213	4,072 Added 64.67%	10,369 $451,000
Q3 2020 Nov 12, 2020	SELL	$37.98 - $48.72 $49,373 - $63,336	-1,300 Reduced 17.11%	6,297 $245,000
Q2 2020 Jul 31, 2020	SELL	$31.07 - $44.74 $100,262 - $144,375	-3,227 Reduced 29.81%	7,597 $329,000
Q1 2020 May 01, 2020	SELL	$22.46 - $42.24 $173,683 - $326,641	-7,733 Reduced 41.67%	10,824 $361,000
Q4 2019 Feb 14, 2020	BUY	$39.01 - $47.51 $277,010 - $337,368	7,101 Added 61.98%	18,557 $769,000
Q3 2019 Nov 14, 2019	BUY	$38.66 - $47.41 $292,617 - $358,846	7,569 Added 194.73%	11,456 $524,000
Q2 2019 Aug 14, 2019	BUY	$38.23 - $47.43 $55,012 - $68,251	1,439 Added 58.78%	3,887 $168,000
Q1 2019 May 14, 2019	SELL	$41.26 - $58.35 $158,520 - $224,180	-3,842 Reduced 61.08%	2,448 $107,000
Q4 2018 Feb 14, 2019	SELL	$44.93 - $73.38 $179,360 - $292,932	-3,992 Reduced 38.83%	6,290 $297,000
Q3 2018 Nov 14, 2018	BUY	$56.85 - $80.35 $124,387 - $175,805	2,188 Added 27.03%	10,282 $768,000
Q2 2018 Aug 14, 2018	BUY	$35.85 - $57.05 $177,887 - $283,082	4,962 Added 158.43%	8,094 $447,000
Q1 2018 May 15, 2018	SELL	$27.0 - $38.5 $21,195 - $30,222	-785 Reduced 20.04%	3,132 $120,000
Q4 2017 Feb 14, 2018	BUY	$28.0 - $33.2 $30,072 - $35,656	1,074 Added 37.78%	3,917 $109,000
Q3 2017 Nov 14, 2017	SELL	$24.5 - $31.1 $14,063 - $17,851	-574 Reduced 16.8%	2,843 $88,000
Q2 2017 Aug 14, 2017	BUY	N/A	1,361 Added 66.2%	3,417 $96,000
Q1 2017 Nov 14, 2017	BUY	N/A	2,056	2,056 $49,000

Others Institutions Holding SRDX

# of Institutions

143

Shares Held

12.4M

Call Options Held

103K

Put Options Held

212K

View Full List

About SURMODICS INC

Ticker SRDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,005,000
Market Cap $453M
Description
Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...

More about SRDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account